OpenURL Connection Search

Select item for more details and to access through your institution.

Nizatidine, an H<sub>2</sub>-Receptor Antagonist: Disposition and Safety in the Elderly.
Published in:
1987
By:
- Callaghan, John T.;
- Rubin, Alan;
- Knadler, Mary Pat;
- Bergstrom, Richard F.
Publication type:
Other
Secretion of nizatidine into human breast milk after single and multiple doses.
Published in:
Clinical Pharmacology & Therapeutics, 1990, v. 47, n. 6, p. 724, doi. 10.1038/clpt.1990.100
By:
- Obermeyer, Boyd D;
- Bergstrom, Richard F;
- Callaghan, John T;
- Knadler, Mary Pat;
- Golichowski, Alan;
- Rubin, Alan
Publication type:
Article
Relationship between steady-state plasma nizatidine concentrations and inhibition of basal and stimulated gastric acid secretion.
Published in:
Clinical Pharmacology & Therapeutics, 1990, v. 47, n. 4, p. 499, doi. 10.1038/clpt.1990.63
By:
- Schneck, Dennis W;
- Callaghan, John T;
- Bergstrom, Richard F;
- Obermeyer, Boyd D;
- Offen, Walter W
Publication type:
Article
Nizatidine disposition in subjects with normal and impaired renal function.
Published in:
Clinical Pharmacology & Therapeutics, 1988, v. 43, n. 6, p. 688, doi. 10.1038/clpt.1988.97
By:
- Aronoff, George R;
- Bergstrom, Richard F;
- Bopp, Ronald J;
- Sloan, Rebecca S;
- Callaghan, John T
Publication type:
Article
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 914, doi. 10.1002/cpt.3402
By:
- Shugg, Tyler;
- Tillman, Emma M.;
- Breman, Amy M.;
- Hodge, Jennelle C.;
- McDonald, Christine A.;
- Ly, Reynold C.;
- Rowe, Elizabeth J.;
- Osei, Wilberforce;
- Smith, Tayler B.;
- Schwartz, Peter H.;
- Callaghan, John T.;
- Pratt, Victoria M.;
- Lynch, Sheryl;
- Eadon, Michael T.;
- Skaar, Todd C.
Publication type:
Article
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Published in:
Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 4, p. 888, doi. 10.1002/cpt.2149
By:
- Crews, Kristine R.;
- Monte, Andrew A.;
- Huddart, Rachel;
- Caudle, Kelly E.;
- Kharasch, Evan D.;
- Gaedigk, Andrea;
- Dunnenberger, Henry M.;
- Leeder, J. Steven;
- Callaghan, John T.;
- Samer, Caroline Flora;
- Klein, Teri E.;
- Haidar, Cyrine E.;
- Van Driest, Sara L.;
- Ruano, Gualberto;
- Sangkuhl, Katrin;
- Cavallari, Larisa H.;
- Müller, Daniel J.;
- Prows, Cynthia A.;
- Nagy, Mohamed;
- Somogyi, Andrew A.
Publication type:
Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update.
Published in:
Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 302, doi. 10.1002/cpt.2008
By:
- Karnes, Jason H.;
- Rettie, Allan E.;
- Somogyi, Andrew A.;
- Huddart, Rachel;
- Fohner, Alison E.;
- Formea, Christine M.;
- Ta Michael Lee, Ming;
- Llerena, Adrian;
- Whirl‐Carrillo, Michelle;
- Klein, Teri E.;
- Phillips, Elizabeth J.;
- Mintzer, Scott;
- Gaedigk, Andrea;
- Caudle, Kelly E.;
- Callaghan, John T.
Publication type:
Article
The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity.
Published in:
British Journal of Clinical Pharmacology, 2002, v. 53, n. 1, p. 67, doi. 10.1046/j.0306-5251.2001.01521.x
By:
- Belle, Donna J.;
- Callaghan, John T.;
- Gorski, J. Christopher;
- Maya, Juan F.;
- Mousa, Omiema;
- Wrighton, Steven A.;
- Hall, Stephen D.
Publication type:
Article
The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective.
Published in:
Journal of Clinical Pharmacology, 2003, v. 43, n. 5, p. 443, doi. 10.1177/0091270003043005001
By:
- Bjornsson, Thorir D.;
- Callaghan, John T.;
- Einolf, Heidi J.;
- Fischer, Volker;
- Gan, Lawrence;
- Grimm, Scott;
- Kao, John;
- King, S. Peter;
- Miwa, Gerald;
- Ni, Lan;
- Kumar, Gondi;
- McLeod, James;
- Obach, Scott R.;
- Roberts, Stanley;
- Roe, Amy;
- Shah, Anita;
- Snikeris, Fred;
- Sullivan, John T.;
- Tweedie, Donald;
- Vega, Jose M.
Publication type:
Article
Olanzapine: Interaction Study with Imipramine.
Published in:
1997
By:
- Callaghan, John T.;
- Cerimele, Benito J.;
- Kassahun, Kelem J.;
- Nyhart, Eldon H.;
- Hoyes-Beehler, Pamela J.;
- Kondraske, George V.
Publication type:
Other
Implementing a pragmatic clinical trial to tailor opioids for chronic pain on behalf of the IGNITE ADOPT PGx investigators.
Published in:
CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70005
By:
- Skaar, Todd C.;
- Myers, Rachel A.;
- Fillingim, Roger B.;
- Callaghan, John T.;
- Cicali, Emily;
- Eadon, Michael T.;
- Elwood, Erica N.;
- Ginsburg, Geoffrey S.;
- Lynch, Sheryl;
- Nguyen, Khoa A.;
- Obeng, Aniwaa Owusu;
- Park, Haesuk;
- Pratt, Victoria M.;
- Rosenman, Marc;
- Sadeghpour, Azita;
- Shuman, Saskia;
- Singh, Rajbir;
- Tillman, Emma M.;
- Volpi, Simona;
- Wiisanen, Kristin
Publication type:
Article
Absorption studies of the H<sub>2</sub>-blocker nizatidine.
Published in:
Clinical Pharmacology & Therapeutics, 1987, v. 42, n. 5, p. 514, doi. 10.1038/clpt.1987.190
By:
- Knadler, Mary Pat;
- Bergstrom, Richard F;
- Callaghan, John T;
- Obermeyer, Boyd D;
- Rubin, Alan
Publication type:
Article
Intravenous nizatidine kinetics and acid suppression.
Published in:
Clinical Pharmacology & Therapeutics, 1985, v. 37, n. 2, p. 162, doi. 10.1038/clpt.1985.29
By:
- Callaghan, John T;
- Bergstrom, Richard F;
- Obermeyer, Boyd D;
- King, Edgar P;
- Offen, Walter W
Publication type:
Article

Found: 13